Investigations into, and development of, a lyophilized and formulated recombinant human factor IX produced from CHO cells
Sign Up to like & getrecommendations! Published in 2017 at "Biotechnology Letters"
DOI: 10.1007/s10529-017-2353-y
Abstract: ObjectivesTo develop a recombinant human factor IX (rFIX) formulation equivalent to commercially available products in terms of cake appearance, residual moisture, proportion of soluble aggregates and activity maintenance for 3 months at 4–8 °C.ResultsNaCl and low bulking… read more here.
Keywords: recombinant human; investigations development; human factor; development lyophilized ... See more keywords